News
The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.
Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...
From eating a healthy diet to minimising stress, here are a few ways to boost immunity, to ward off infections.
18h
Best Life on MSNScientists Find Shocking Link Between COVID and Alzheimer’sThe brain fog that can linger after a bout with COVID is not a new discovery. In fact, much research has linked this long-COVID symptom to the neuroinflammation that often accompanies an infection.
During a live event, Jorge Monge, MD, discussed short and long-term adverse events associated with CAR T-cell therapy in ...
2d
Verywell Health on MSNWhat Happens to Your Body When You Eat ProteinProtein gives you energy thanks to amino acids. Learn why researchers want to reassess daily protein recommendations and what ...
Researchers sought to determine whether dual-targeted CAR-T therapy would be effective for patients with relapsed or refractory MCL.
Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment.
Cats with a severe coronavirus disease experienced an immune system boost after treatment with an MSC therapy, opening translational avenues for humans.
Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.
Genetic Leap, a clinical stage, AI-native biotech pioneering RNA genetic therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results